These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 16609154)

  • 21. Identification of hepatitis C virus genotype 6 in Korean patients by analysis of 5' untranslated region using a matrix assisted laser desorption/ionization time of flight-based assay, restriction fragment mass polymorphism.
    Oh HB; Kim SO; Cha CH; Hong SP; Folk WR; Kim KM; Suh DJ
    J Med Virol; 2008 Oct; 80(10):1712-9. PubMed ID: 18712825
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of epitope-specific anti-hepatitis C virus E2 (anti-HCV/E2) antibodies by anti-viral treatment.
    Mancini N; Carletti S; Perotti M; Romanò L; Craxì RD; Craxì A; Zanetti AR; Clementi M; Burioni R
    J Med Virol; 2006 Oct; 78(10):1304-11. PubMed ID: 16927283
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of low-dose intermittent interferon-alpha monotherapy in patients infected with hepatitis C virus genotype 1b who were predicted or failed to respond to pegylated interferon plus ribavirin combination therapy.
    Akuta N; Suzuki F; Kawamura Y; Yatsuji H; Sezaki H; Suzuki Y; Hosaka T; Kobayashi M; Kobayashi M; Arase Y; Ikeda K; Kumada H
    J Med Virol; 2008 Aug; 80(8):1363-9. PubMed ID: 18551610
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tailored treatment for hepatitis C.
    Berg T
    Clin Liver Dis; 2008 Aug; 12(3):507-28, vii-viii. PubMed ID: 18625426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adiponectin: a new independent predictor of liver steatosis and response to IFN-alpha treatment in chronic hepatitis C.
    Zografos TA; Liaskos C; Rigopoulou EI; Togousidis E; Makaritsis K; Germenis A; Dalekos GN
    Am J Gastroenterol; 2008 Mar; 103(3):605-14. PubMed ID: 18190648
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HCV kinetics, quasispecies, and clearance in treated HCV-infected and HCV/HIV-1-coinfected patients with hemophilia.
    Shire NJ; Horn PS; Rouster SD; Stanford S; Eyster ME; Sherman KE;
    Hepatology; 2006 Nov; 44(5):1146-57. PubMed ID: 17058240
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Structure and replication of viral hepatitis C virus, the key of the future therapeutic goals].
    Grigorescu O; Luca CM; Moraru E
    Rev Med Chir Soc Med Nat Iasi; 2008; 112(4):877-81. PubMed ID: 20209756
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hepatitis C virus--structure, replication and therapeutical opportunities and the phenomenon of resistance].
    Kowala-Piaskowska A
    Postepy Biochem; 2006; 52(4):399-407. PubMed ID: 17536509
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis C virus genotypes and viral concentrations in participants of a general population survey in the United States.
    Nainan OV; Alter MJ; Kruszon-Moran D; Gao FX; Xia G; McQuillan G; Margolis HS
    Gastroenterology; 2006 Aug; 131(2):478-84. PubMed ID: 16890602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oligonucleotide-based therapeutic options against hepatitis C virus infection.
    Trepanier JB; Tanner JE; Alfieri C
    Antivir Ther; 2006; 11(3):273-87. PubMed ID: 16759043
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and therapeutic implications of hepatitis C virus compartmentalization.
    Di Liberto G; Roque-Afonso AM; Kara R; Ducoulombier D; Fallot G; Samuel D; Feray C
    Gastroenterology; 2006 Jul; 131(1):76-84. PubMed ID: 16831592
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Asian Pacific Association for the Study of the Liver consensus statements on the diagnosis, management and treatment of hepatitis C virus infection.
    ; McCaughan GW; Omata M; Amarapurkar D; Bowden S; Chow WC; Chutaputti A; Dore G; Gane E; Guan R; Hamid SS; Hardikar W; Hui CK; Jafri W; Jia JD; Lai MY; Wei L; Leung N; Piratvisuth T; Sarin S; Sollano J; Tateishi R
    J Gastroenterol Hepatol; 2007 May; 22(5):615-33. PubMed ID: 17444847
    [No Abstract]   [Full Text] [Related]  

  • 33. [Viral quasispecies and their implications in antiviral therapy].
    Fernández B; Basaras M; Blanco S; Sánchez S; Arrese E; de las Heras B; Cisterna R
    Rev Esp Quimioter; 2002 Mar; 15(1):49-54. PubMed ID: 12582437
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The hepatitis C virus life cycle as a target for new antiviral therapies.
    Pawlotsky JM; Chevaliez S; McHutchison JG
    Gastroenterology; 2007 May; 132(5):1979-98. PubMed ID: 17484890
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent advances in the discovery of small molecule therapies for HCV.
    Myles DC
    Curr Opin Drug Discov Devel; 2001 Jul; 4(4):411-6. PubMed ID: 11727306
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association with 5'-untranslated region and response to interferon in chronic hepatitis C.
    Katano Y; Hayashi K; Ishigami M; Itoh A; Hirooka Y; Nakano I; Goto H
    Hepatogastroenterology; 2007; 54(75):854-7. PubMed ID: 17591078
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis C in dialysis units: the Saudi experience.
    Karkar A
    Hemodial Int; 2007 Jul; 11(3):354-67. PubMed ID: 17576302
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genotype III - HCV infection.
    Amarapurkar DN; Choksi M
    Trop Gastroenterol; 2007; 28(2):58-63. PubMed ID: 18050840
    [No Abstract]   [Full Text] [Related]  

  • 39. HCV genotypes--role in pathogenesis of disease and response to therapy.
    Webster G; Barnes E; Brown D; Dusheiko G
    Baillieres Best Pract Res Clin Gastroenterol; 2000 Apr; 14(2):229-40. PubMed ID: 10890318
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical and morphological picture of hepatitis C in children with genotype 4c4d].
    Czerwionka-Szaflarska M; Chrobot A; Szaflarska-Szczepanik A; Chrobot A
    Pol Merkur Lekarski; 1999 Feb; 6(32):68-9. PubMed ID: 10337173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.